Irish Journal of Medical Science

, Volume 181, Issue 4, pp 453–457 | Cite as

Can enhanced recovery programmes be further improved by the addition of omega three fatty acids?

  • D. K. Bilku
  • T. C. Hall
  • D. Al-Leswas
  • A. R. Dennison
Review Article

Abstract

Aims

The term “enhanced recovery programme (ERP)” means applying defined protocols to augment the recovery of patients following surgery. Inflammation is body’s response to insults such as infection, injury and surgical procedures. Inflammatory mediators whose function is initially protective may cause undesirable consequences, if the response is unnecessarily prolonged. The principle effects of ERP result from the reduction of the profound stress which results following major surgical procedures.

Methods

A Pubmed literature search was undertaken using the keywords enhanced recovery, surgery and omega-3. The primary endpoint was whether the addition of omega-3 to ERP improved morbidity and mortality.

Results

Nine randomised trials examining the effect of omega-3 enriched diets following surgery were analysed. Inclusion of omega-3 helps in maintaining a positive nitrogen balance, overcome immune dysfunction, lower the incidence of post-operative infections with the consequence of reduced morbidity and mortality.

Conclusions

The provision of early or continuous nutrition is one of the cornerstones of an ERP. A theoretically ideal regimen would provide an energy substrate and protein and contain a component which would limit inappropriate inflammation. The beneficial role of omega-3 results from a number of effects which limit the inflammatory response, principally by influencing the production of eicosanoids and modulating cytokines. They also enhance cell-mediated immunity and preserve immune function better than standard dietary formulations. Although ERPs have already produced significant progress, there is sufficient evidence to suggest that the provision of omega-3 fatty acids may result in further improvements.

Keywords

Enhanced recovery programme Omega-3 fatty acids Surgery 

References

  1. 1.
    Edwards G, Morton HJV, Pask EA, Wylie WD (1956) Deaths associated with anaesthesia: a report on 1,000 cases. Anaesthesia 11:194–220PubMedCrossRefGoogle Scholar
  2. 2.
    Bannister WK, Sattilaro AJ (1962) Vomiting and aspiration during anesthesia. Anesthesiology 23:251–264PubMedCrossRefGoogle Scholar
  3. 3.
    Marshall BM, Gordon RA (1958) Vomiting, regurgitation, and aspiration in anaesthesia II. Can Anaesth Soc J 5:439–447Google Scholar
  4. 4.
    Mendelson CL (1946) The aspiration of stomach contents into the lungs during obstetric anaesthesia. Am J Obstet Gynecol 52:191–205PubMedGoogle Scholar
  5. 5.
    Wilmore DW (1991) Catabolic illness. Strategies for enhancing recovery. N Engl J Med 325:695–702PubMedCrossRefGoogle Scholar
  6. 6.
    Chang DW, DeSanti L, Demling RH (1998) Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock 10:155–160PubMedCrossRefGoogle Scholar
  7. 7.
    Basse L, Hjort Jakobsen D, Billesbølle P, Werner M, Kehlet H (2000) A clinical pathway to accelerate recovery after colonic resection. Ann Surg 232:51–57PubMedCrossRefGoogle Scholar
  8. 8.
    Wind J, Polle SW, Fung Kon Jin PH et al (2006) Laparoscopy and/or fast track multimodal management versus standard care (LAFA) study group; enhanced recovery after surgery (ERAS) group. Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg 93(7):800–809PubMedCrossRefGoogle Scholar
  9. 9.
    Fearon KC, Ljungqvist O, Von Meyenfeldt M et al (2005) Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. Clin Nutr 24(3):466–477PubMedCrossRefGoogle Scholar
  10. 10.
    Walter CJ, Collin J, Dumville JC, Drew PJ, Monson JR (2009) Enhanced recovery in colorectal resections: a systematic review and meta-analysis. Colorectal Dis 11(4):344–353PubMedCrossRefGoogle Scholar
  11. 11.
    Calder PC (2002) Dietary modification of inflammation with lipids. Proc Nutr Soc 61(3):345–358PubMedCrossRefGoogle Scholar
  12. 12.
    Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68(5):280–289PubMedCrossRefGoogle Scholar
  13. 13.
    Braga M, Gianotti L, Nespoli L, Radaelli G, Di Carlo V (2002) Nutritional approach in malnourished surgical patients. Arch Surg 137(2):174–180PubMedCrossRefGoogle Scholar
  14. 14.
    Daly JM, Lieberman MD, Goldfine J et al (1992) Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 112(1):56–67PubMedGoogle Scholar
  15. 15.
    Kemen M, Senkal M, Homann HH et al (1995) Early postoperative enteral nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med 23(4):652–659PubMedCrossRefGoogle Scholar
  16. 16.
    Braga M, Gianotti L, Radaelli G et al (1999) Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 134(4):428–433PubMedCrossRefGoogle Scholar
  17. 17.
    Gianotti L, Braga M, Fortis C (1999) A prospective, randomized clinical trial on perioperative feeding with an arginine, omega-3 fatty acid and RNA-enriched enteral diet: effect on host response and nutritional status. J Parenter Enteral Nutr 23(6):314–320CrossRefGoogle Scholar
  18. 18.
    Braga M, Gianotti L, Vignali A, Carlo VD (2002) Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 132(5):805–814PubMedCrossRefGoogle Scholar
  19. 19.
    Senkal M, Zumtobel V, Bauer KH et al (1999) Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 134(12):1309–1316PubMedCrossRefGoogle Scholar
  20. 20.
    Senkal M, Mumme A, Eickhoff U et al (1997) Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 25(9):1489–1496PubMedCrossRefGoogle Scholar
  21. 21.
    Tepaske R, Velthuis H, Oudemans Straaten HM van (2001) Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 358(9283):696–701PubMedCrossRefGoogle Scholar
  22. 22.
    Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2(8081):117–119PubMedCrossRefGoogle Scholar
  23. 23.
    Calder PC, Jensen GL, Koletzko BV, Singer P, Wanten GJ (2010) Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med 36(5):735–749PubMedCrossRefGoogle Scholar
  24. 24.
    Calder PC (2004) n-3 fatty acids, inflammation, and immunity–relevance to postsurgical and critically ill patients. Lipids 39(12):1147–1161PubMedCrossRefGoogle Scholar
  25. 25.
    Lee TH, Hoover RL, Williams JD et al (1985) Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. New Engl J Med 312:1217–1224PubMedCrossRefGoogle Scholar
  26. 26.
    Sperling RI, Benincaso AI, Knoell CT, Larkin JK, Austen KF, Robinson DR (1993) Dietary n-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91:651–660PubMedCrossRefGoogle Scholar
  27. 27.
    Stenson WF, Cort D, Rodgers J et al (1992) Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116:609–614PubMedGoogle Scholar
  28. 28.
    Hawthorne AB, Daneshmend TK, Hawkey CJ et al (1992) Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33:922–928PubMedCrossRefGoogle Scholar
  29. 29.
    Galli C, Calder PC (2009) Effects of fat and fatty acid intake on inflammatory and immune responses: a critical review. Ann Nutr Metab 55(1–3):123–139PubMedCrossRefGoogle Scholar
  30. 30.
    Liang B, Wang S, Ye YJ et al (2008) Impact of postoperative omega-3 fatty acid supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol 14(15):2434–2439PubMedCrossRefGoogle Scholar
  31. 31.
    Wachtler P, König W, Senkal M, Kemen M, Köller M (1997) Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 42(2):191–198PubMedCrossRefGoogle Scholar
  32. 32.
    Hayashi N, Tashiro T, Yamamori H et al (1998) Effects of intravenous omega-3 and omega-6 fat emulsion on cytokine production and delayed type hypersensitivity in burned rats receiving total parenteral nutrition. J Parenter Enteral Nutr 22(6):363–367CrossRefGoogle Scholar
  33. 33.
    Meakins JL, Pietsch JB, Bubenick O et al (1977) Delayed hypersensitivity: indicator of acquired failure of host defences in sepsis and trauma. Ann Surg 186:241–250PubMedCrossRefGoogle Scholar
  34. 34.
    Lederer JA, Rodrick ML, Mannick JA (1999) The effects of injury on the adaptive immune response. Shock 11:153–159PubMedCrossRefGoogle Scholar
  35. 35.
    Oberholzer A, Oberholzer C, Moldawer LL (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83–96PubMedCrossRefGoogle Scholar
  36. 36.
    Lin MT, Yeh SL, Yeh CL et al (2006) Parenteral N-3 fatty acids modulate inflammatory and immune response in rats undergoing total gastrectomy. Shock 25(1):5660CrossRefGoogle Scholar
  37. 37.
    Calder PC, Yaqoob P (2009) Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 121(6):148–157PubMedCrossRefGoogle Scholar
  38. 38.
    Waitzberg DL, Torrinhas RS (2009) Fish oil lipid emulsions and immune response: what clinicians need to know. Nutr Clin Pract 24(4):487–499PubMedCrossRefGoogle Scholar
  39. 39.
    Calder PC (2006) Use of fish oil in parenteral nutrition: Rationale and reality. Proc Nutr Soc 65(3):264–277PubMedCrossRefGoogle Scholar
  40. 40.
    Delaney CP, Zutshi M, Senagore AJ, Remzi FH, Hammel J, Fazio VW (2003) Prospective, randomised controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 46:851–859PubMedCrossRefGoogle Scholar
  41. 41.
    Weimann A, Braga M, Harsanyi L, ESPEN (European Society for Parenteral and Enteral Nutrition) et al (2006) ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr 25(2):224–244PubMedCrossRefGoogle Scholar

Copyright information

© Royal Academy of Medicine in Ireland 2012

Authors and Affiliations

  • D. K. Bilku
    • 1
  • T. C. Hall
    • 1
  • D. Al-Leswas
    • 1
  • A. R. Dennison
    • 1
  1. 1.Department of Surgery, Leicester General HospitalUniversity Hospitals of Leicester NHS TrustLeicesterUK

Personalised recommendations